Ardent Health Files Registration Statement for Proposed Initial Public Offering
June 21 2024 - 5:47PM
Business Wire
Ardent Health Partners, LLC (“Ardent Health”) today announced it
has publicly filed a registration statement on Form S-1 (the
“Registration Statement”) with the U.S. Securities and Exchange
Commission (the “SEC”) relating to the proposed initial public
offering of its common stock. The number of shares to be offered
and the price range for the proposed offering have not yet been
determined. The offering is subject to market conditions, and there
can be no assurance as to whether or when the offering may be
completed, or as to the actual size or terms of the offering.
Ardent Health has applied to list its common stock on the New York
Stock Exchange under the ticker symbol “ARDT.”
Ardent Health intends to use the net proceeds from the proposed
offering to repay certain existing indebtedness and for general
corporate purposes.
J.P. Morgan, BofA Securities and Morgan Stanley will act as lead
book-running managers for the proposed offering. Stephens Inc.,
Citigroup, Leerink Partners, RBC Capital Markets, Truist
Securities, and Mizuho will also act as bookrunners for the
proposed offering. Capital One Securities and Loop Capital Markets
will act as co-managers for the proposed offering.
The proposed offering will be made only by means of a
prospectus, which forms a part of the Registration Statement. Once
available, copies of the Registration Statement and preliminary
prospectus included therein relating to this proposed offering may
be obtained for free by visiting EDGAR on the SEC’s website at
www.sec.gov. Alternatively, copies of the prospectus, when
available, may be obtained from J.P. Morgan Securities LLC, c/o
Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood,
NY 11717, by telephone at 866-803-9204 or by email at
prospectus-eq_fi@jpmorganchase.com; BofA Securities, NC1-022-02-25,
201 North Tryon Street, Charlotte, NC, 28255-0001, Attn: Prospectus
Department, by telephone at 800-294-1322 or by email at
dg.prospectus_requests@bofa.com; or Morgan Stanley & Co. LLC,
Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New
York, NY 10014.
The Registration Statement relating to the proposed offering has
been filed with the SEC but has not yet become effective. These
securities may not be sold, nor may offers to buy be accepted,
prior to the time the Registration Statement becomes effective.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy any securities, nor shall there be
any sale of these securities in any state or jurisdiction in which
such an offer, solicitation, or sale would be unlawful prior to
registration or qualification under the securities laws of any such
state or jurisdiction. Any offers, solicitations or offers to buy,
or any sales of securities will be made in accordance with the
registration requirements of the Securities Act of 1933, as
amended.
About Ardent Health Ardent Health is a leading provider
of healthcare in growing midsize urban communities across the
country. With a focus on people and investments in innovative
services and technologies, Ardent Health is passionate about making
healthcare better and easier to access. Through its subsidiaries,
Ardent Health delivers care through a system of 30 acute care
hospitals and more than 200 sites of care with over 1,700 providers
across six states.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240621288579/en/
Media Relations: Rebecca Kirkham Ardent Health
rebecca.kirkham@ardenthealth.com
Investor Relations: Stefan Neely Vallum Advisors
ARDT@val-adv.com